Moteur de recherche d’entreprises européennes
Financement de l’UE (32,3 M €) : Référentiel central pour la pathologie numérique Hor04/12/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Référentiel central pour la pathologie numérique
BIGPICTURE, a pathology-led consortium, has the vision to become the catalyst in digital transformation in Pathology. Our mission is to create the first European GDPR compliant platform, in which both quality-controlled Whole Slide Imaging (WSI) data and advanced Artificial intelligence (AI) algorithms will exist. The BIGPICTURE platform will be built on existing assets of ELIXIR EU data infrastructure, including the federated European Genome-phenome Archive (EGA) technology for managing the exchange of confidential information between contributors and users. The consortium will use Cytomine, an established open-source, cross-platform framework to develop unique tools for access to WSI, including annotations and visualisation of algorithm results, while we will develop new and generic models to facilitate AI development and mining of WSI data. By engaging and building consensus with all the relevant stakeholders, we will contribute to the development of a regulatory framework for digital slides and AI-based methods. Finally, BIGPICTURE envisions sustainability of its platform through a community- based model which relies on reciprocity, value creation and inclusiveness. To achieve our vision, we have brought together Europe’s leaders in the field of computational pathology who have access to national and European high-performance computing infrastructures as well as Europe’s fully digitalised pathology departments. Additionally, the consortium has currently access to approximately 4.5 million clinical WSI covering a wider range of indications through 17 partners and 23 third parties from the largest European and international pathology and trial groups. Our consortium is further strengthened by the presence of the European Society of Pathology, Digital Pathology Association, FDA and 9 SMEs as partners, while we are further supported by professional societies, and patient advocates.
| 2 152,50 € | |
| BAYER AG | 0,00 € |
| 0,00 € | |
| Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) | 380 000 € |
| CSC-TIETEEN TIETOTEKNIIKAN KESKUS Oy | 4 003 125 € |
| Cytomine | 0,00 € |
| Cytomine Corporation SA | 518 750 € |
| 2 450 000 € | |
| DIN DEUTSCHES INSTITUT für NORMUNG e. V. | 98 413 € |
| Diagnexia UK Ltd. | 0,00 € |
| Digital Pathology Association Inc. | 12 000,00 € |
| European Society OF Pathology | 60 000 € |
| F. HOFFMANN-LA ROCHE AG | 0,00 € |
| FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. | 240 006 € |
| GBG FORSCHUNGS GmbH | 72 000 € |
| 300 000 € | |
| 900 000 € | |
| Institut Pasteur | 378 125 € |
| Institut de Recherches Internationales Servier Iris | 0,00 € |
| Janssen Pharmaceutica N.V. | 0,00 € |
| Katholieke Universiteit Leuven | 0,00 € |
| 2 163 750 € | |
| Medizinische Universitaet Wien | 619 430 € |
| 232 000 € | |
| NOVARTIS PHARMA AG | 0,00 € |
| Novo Nordisk A/S | 0,00 € |
| Owkin France | 400 000 € |
| PHILIPPS UNIVERSITAET MARBURG | 600 000 € |
| Pfizer Ltd. | 0,00 € |
| 270 000 € | |
| 600 000 € | |
| Sanofi-Aventis Recherche & Developpement | 0,00 € |
| Sectra AB | 196 875 € |
| Semmelweis Egyetem | 72 000 € |
| Stichting HET Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | 200 000 € |
| Stichting Lygature | 1 724 000 € |
| Stichting Radboud Universitair Medisch Centrum | 8 614 691 € |
| 0,00 € | |
| TECHNISCHE UNIVERSITAET MUENCHEN | 312 000 € |
| THE European Institute for Innovation Through Health Data | 60 000 € |
| TURUN YLIOPISTO | 0,00 € |
| Technische Universiteit Eindhoven | 240 000 € |
| 950 150 € | |
| Timelex | 240 000 € |
| 160 000 € | |
| UCB Biopharma | 0,00 € |
| Umea Universitet | 0,00 € |
| Universita' Degli Studi DI Milano-Bicocca | 0,00 € |
| Universitair Medisch Centrum Utrecht | 600 000 € |
| Universite de Liege | 1 625 375 € |
| University of Warwick | 399 983 € |
| Uppsala Universitet | 2 625 000 € |
https://cordis.europa.eu/project/id/945358
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "Azienda Ospedaliera Per L Emergenza Cannizzaro - Financement de l’UE (32,3 M €) : Référentiel central pour la pathologie numérique"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
